One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.

MLA

Jourdan, Eric, et al. “One versus Two High-Dose Cytarabine-Based Consolidation before Autologous Stem Cell Transplantation for Young Acute Myeloblastic Leukaemia Patients in First Complete Remission.” British Journal of Haematology, vol. 129, no. 3, May 2005, pp. 403–10. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2005.05470.x.

APA

Jourdan, E., Rigal-Huguet, F., Marit, G., Vey, N., Dastugue, N., Fegueux, N., Molina, L., Gastaut, J.-A., Legros, L., Zerazhi, H., Cailleres, S., Bauduer, F., Bordessoule, D., Attal, M., Blaise, D., & Pigneux, A. (2005). One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission. British Journal of Haematology, 129(3), 403–410. https://doi.org/10.1111/j.1365-2141.2005.05470.x

Chicago

Jourdan, Eric, Françoise Rigal-Huguet, Gerald Marit, Norbert Vey, Nicole Dastugue, Nathalie Fegueux, Lysiane Molina, et al. 2005. “One versus Two High-Dose Cytarabine-Based Consolidation before Autologous Stem Cell Transplantation for Young Acute Myeloblastic Leukaemia Patients in First Complete Remission.” British Journal of Haematology 129 (3): 403–10. doi:10.1111/j.1365-2141.2005.05470.x.